Key result
Sublingual nitroglycerin decreased blood volume over the thorax and liver, and increased it over the abdomen and legs.
Why the study?
Does sublingual nitroglycerin alter the distribution of blood volume in patients with congestive heart failure?
RCT (n=16)
Randomly assigned
Does sublingual nitroglycerin alter the distribution of blood volume in patients with congestive heart failure?
Sublingual nitroglycerin causes an immediate redistribution of blood volume from the thorax and liver to the abdomen and legs in patients with congestive heart failure.
Answers are grounded in this paper and cite their sources.
Reinforces sublingual nitroglycerin for acute preload reduction in HF; extends evidence on regional blood volume redistribution.
The effect of sublingually administered nitroglycerin (0.5 mg) on distribution of blood volume in 16 patients with congestive heart failure (NYHA class II and III), randomly assigned to placebo (N = 8) or nitroglycerin (N = 8) was studied 20 minutes after in vivo labelling of red blood cells with 99m-Tc pertechnetate. Count rates over thorax, abdomen and legs were collected with a large field gamma camera and expressed as percentage changes of baseline value. Changes in count rates, averaged for 5, 10 and 15 minutes after drug administration showed a significant decrease in the nitroglycerin group as compared to the placebo group over the thorax (mean 5%, P less than 0.01) and over the liver (mean 5%, P less than 0.05) and a significant increase over the abdomen (mean 4%, P less than 0.01) and the legs (mean 9%, P less than 0.01). After nitroglycerin, the changes in pulmonary activity were variable and did not differ from the placebo group. These results indicate that nitroglycerin causes a redistribution of blood volume in patients with congestive heart failure. An increase in the vascular capacitance in the abdomen and legs may be responsible for a decrease of blood volume of the thorax and the liver in these patients.
No takes yet. Share an insight, caveat, or question.
Schneider et al. (1987) conducted an RCT in Congestive heart failure (n=16). Nitroglycerin vs. Placebo was evaluated on Percentage changes of baseline value in count rates over thorax, liver, abdomen, and legs (p=<0.01). Sublingual nitroglycerin decreased blood volume over the thorax and liver, and increased it over the abdomen and legs.
Synapse has enriched 10 related papers. Consider them for comparative context: